These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 22626984)

  • 1. Multi-color CD34⁺ progenitor-focused flow cytometric assay in evaluation of myelodysplastic syndromes in patients with post cancer therapy cytopenia.
    Tang G; Jorgensen LJ; Zhou Y; Hu Y; Kersh M; Garcia-Manero G; Medeiros LJ; Wang SA
    Leuk Res; 2012 Aug; 36(8):974-81. PubMed ID: 22626984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring blast composition in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms: CD45RA and CD371 improve diagnostic value of flow cytometry through assessment of myeloblast heterogeneity and stem cell aberrancy.
    Shameli A; Dharmani-Khan P; Luider J; Auer I; Shabani-Rad MT
    Cytometry B Clin Cytom; 2021 Sep; 100(5):574-589. PubMed ID: 33369070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Revising flow cytometric mini-panel for diagnosing low-grade myelodysplastic syndromes: Introducing a parameter quantifying CD33 expression on CD34+ cells.
    Ogata K; Sei K; Saft L; Kawahara N; Porta MGD; Chapuis N; Yamamoto Y
    Leuk Res; 2018 Aug; 71():75-81. PubMed ID: 30025279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of molecular targets on the surface of CD34+CD38- bone marrow cells in myelodysplastic syndromes.
    Xie W; Wang X; Du W; Liu W; Qin X; Huang S
    Cytometry A; 2010 Sep; 77(9):840-8. PubMed ID: 20662087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishment and validation of an updated diagnostic FCM scoring system based on pooled immunophenotyping in CD34+ blasts and its clinical significance for myelodysplastic syndromes.
    Xu F; Li X; Chang CK; Guo J; Wu LY; He Q; Zhang Z; Zhu Y; Gu SC; Shi WH; Song LX; Su JY; Zhou LY; Zhang X; Wu D
    PLoS One; 2014; 9(2):e88706. PubMed ID: 24558415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-Grade Myelodysplastic Syndromes with Preserved CD34+ B-Cell Precursors (CD34+ Hematogones).
    Chen Z; Ok CY; Wang W; Goswami M; Tang G; Routbort M; Jorgensen JL; Medeiros LJ; Wang SA
    Cytometry B Clin Cytom; 2020 Jan; 98(1):36-42. PubMed ID: 31211490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunophenotypic Profile of CD34+ Subpopulations and Their Role in the Diagnosis and Prognosis of Patients with De-Novo, Particularly Low-Grade Myelodysplastic Syndromes.
    Gardikas N; Vikentiou M; Konsta E; Kontos CK; Papageorgiou SG; Spathis A; Bazani E; Bouchla A; Kapsimali V; Psarra K; Foukas P; Dimitriadis G; Pappa V
    Cytometry B Clin Cytom; 2019 Jan; 96(1):73-82. PubMed ID: 30334347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic application and clinical significance of FCM progress scoring system based on immunophenotyping in CD34+ blasts in myelodysplastic syndromes.
    Xu F; Guo J; Wu LY; He Q; Zhang Z; Chang CK; Li X
    Cytometry B Clin Cytom; 2013; 84(4):267-78. PubMed ID: 23554290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flow cytometry in myelodysplastic syndrome: analysis of diagnostic utility using maturation pattern-based and quantitative approaches.
    Chopra A; Pati H; Mahapatra M; Mishra P; Seth T; Kumar S; Singh S; Pandey S; Kumar R
    Ann Hematol; 2012 Sep; 91(9):1351-62. PubMed ID: 22526362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative multi-color flow cytometric analysis of cell surface antigens in bone marrow hematopoietic progenitors between refractory anemia and aplastic anemia.
    Otawa M; Kawanishi Y; Iwase O; Shoji N; Miyazawa K; Ohyashiki K
    Leuk Res; 2000 Apr; 24(4):359-66. PubMed ID: 10713334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deep immunophenotypic analysis of the bone marrow progenitor cells in myelodysplastic syndromes.
    Shameli A; Dharmani-Khan P; Auer I; Shabani-Rad MT
    Leuk Res; 2023 Nov; 134():107401. PubMed ID: 37774446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic potential of CD34+ cell antigen expression in myelodysplastic syndromes.
    De Smet D; Trullemans F; Jochmans K; Renmans W; Smet L; Heylen O; Bael AM; Schots R; Leus B; De Waele M
    Am J Clin Pathol; 2012 Nov; 138(5):732-43. PubMed ID: 23086775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Four-color flow cytometric immunophenotypic features of blasts in myelodysplastic syndromes].
    Wu YJ; Li JY; Qiu HR; Xiao B; Zhang JF; Song JH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Feb; 14(1):50-3. PubMed ID: 16584591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flow cytometry to distinguish myelodysplastic syndromes from non-neoplastic causes of cytopenia: ready for prime time?
    Hasserjian RP; Preffer FI
    Leuk Res; 2012 Sep; 36(9):1089-90. PubMed ID: 22727507
    [No Abstract]   [Full Text] [Related]  

  • 15. [Diagnostic significance of immunophenotyping of bone marrow cells in myelodysplastic syndrome without an increase of marrow blasts].
    Xu J; Zhang W; Liu Y; Wan SG; Sun XJ; Zhao H
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Dec; 17(6):1477-81. PubMed ID: 20030930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myelodysplastic neoplasms dissected into indolent, leukaemic and unfavourable subtypes by computational clustering of haematopoietic stem and progenitor cells.
    van Spronsen MF; Van Gassen S; Duetz C; Westers TM; Saeys Y; van de Loosdrecht AA
    Leukemia; 2024 Jun; 38(6):1365-1377. PubMed ID: 38459168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flow cytometry immunophenotyping in integrated diagnostics of patients with newly diagnosed cytopenia: one tube 10-color 14-antibody screening panel and 3-tube extensive panel for detection of MDS-related features.
    Porwit A; Rajab A
    Int J Lab Hematol; 2015 May; 37 Suppl 1():133-43. PubMed ID: 25976971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased CD34+CD38 -CD123 + cells in myelodysplastic syndrome displaying malignant features similar to those in AML.
    Li LJ; Tao JL; Fu R; Wang HQ; Jiang HJ; Yue LZ; Zhang W; Liu H; Shao ZH
    Int J Hematol; 2014 Jul; 100(1):60-9. PubMed ID: 24846193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone marrow cells from myelodysplastic syndromes show altered immunophenotypic profiles that may contribute to the diagnosis and prognostic stratification of the disease: a pilot study on a series of 56 patients.
    Matarraz S; López A; Barrena S; Fernandez C; Jensen E; Flores-Montero J; Rasillo A; Sayagues JM; Sánchez ML; Bárcena P; Hernandez-Rivas JM; Salvador C; Fernandez-Mosteirín N; Giralt M; Perdiguer L; Laranjeira P; Paiva A; Orfao A
    Cytometry B Clin Cytom; 2010 May; 78(3):154-68. PubMed ID: 20198685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening bone marrow samples for abnormal lymphoid populations and myelodysplasia-related features with one 10-color 14-antibody screening tube.
    Rajab A; Porwit A
    Cytometry B Clin Cytom; 2015; 88(4):253-60. PubMed ID: 25664445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.